| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.066 | 0.4 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.4 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |